Evaluation of the Effect of Pectoral Nerve Block II on Acute and Chronic Pain in Patients Undergoing Oncological Breast Surgery
NCT ID: NCT06718868
Last Updated: 2024-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2024-01-05
2024-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Is PECSII blockade applied to patients undergoing oncological breast surgery effective on acute pain scores compared to the non-blockade group? Is there a difference between the group with block and the group without block in terms of the development of chronic pain in the evaluation made at the 3rd month after surgery? The analgesia method applied to the patients will be recorded in the patient files and acute and chronic pain scores will be evaluated. Chronic pain score evaluation will be made by telephone survey.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients in Group 1 were defined as those who received PECSII Block in addition to intravenous analgesia.
No interventions assigned to this group
Group 2
Patients in Group 2 were defined as patients who received intravenous analgesia only.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA score I-II-III patients
* Non-pregnant patients
* Patients who agreed to participate in the study
Exclusion Criteria
* Patients who underwent bilateral mastectomy
* Patients with chest wall anomalies
* Patients with neuropathic pain before surgery
* Patients who did not agree to participate in the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Irem Erkan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Irem Erkan
Resident Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Serap Karacalar, Prof.
Role: STUDY_DIRECTOR
Prof. Dr. Cemil Tascioglu Education and Research Hospital
İrem Erkan, M.D.
Role: PRINCIPAL_INVESTIGATOR
Prof. Dr. Cemil Tascioglu Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. Cemil Tascıoglu Education and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-48670771-514.99-232052317
Identifier Type: -
Identifier Source: org_study_id